Jinghua Pharmaceutical Group Co., Ltd. (SHE:002349)
8.00
-0.11 (-1.36%)
Dec 5, 2025, 3:04 PM CST
SHE:002349 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 1,436 | 1,388 | 1,496 | 1,550 | 1,336 | 1,256 | Upgrade |
Other Revenue | 13.63 | 13.63 | 15.41 | 22.58 | 21.41 | 25.31 | Upgrade |
| 1,449 | 1,402 | 1,512 | 1,573 | 1,358 | 1,281 | Upgrade | |
Revenue Growth (YoY) | 0.83% | -7.25% | -3.90% | 15.85% | 5.97% | 10.71% | Upgrade |
Cost of Revenue | 712.86 | 719.73 | 781.18 | 847.06 | 739.21 | 695.09 | Upgrade |
Gross Profit | 736.34 | 682.36 | 730.58 | 726 | 618.66 | 586.27 | Upgrade |
Selling, General & Admin | 391.6 | 366.72 | 346.78 | 401.01 | 352.64 | 302.35 | Upgrade |
Research & Development | 58.18 | 61.79 | 64.62 | 86.98 | 74.76 | 52.05 | Upgrade |
Other Operating Expenses | 24.5 | 17.48 | 17.77 | 22.39 | 20.17 | 19.71 | Upgrade |
Operating Expenses | 476.13 | 449.36 | 431.89 | 514.64 | 462.16 | 372.54 | Upgrade |
Operating Income | 260.2 | 233 | 298.69 | 211.36 | 156.51 | 213.73 | Upgrade |
Interest Expense | - | -1.34 | -2.57 | -6.79 | -12.94 | -19.65 | Upgrade |
Interest & Investment Income | 36.89 | 48.38 | 23.87 | 39.71 | 14.16 | 23.27 | Upgrade |
Currency Exchange Gain (Loss) | 2.34 | 2.34 | 2.35 | 6.86 | -1.48 | -6.19 | Upgrade |
Other Non Operating Income (Expenses) | 2.49 | -0.3 | 0.43 | -1.24 | 1.45 | -1.58 | Upgrade |
EBT Excluding Unusual Items | 301.92 | 282.09 | 322.76 | 249.9 | 157.7 | 209.58 | Upgrade |
Impairment of Goodwill | - | - | - | - | - | -5.56 | Upgrade |
Gain (Loss) on Sale of Investments | 3.28 | 3.82 | 6.83 | 4.99 | 31.44 | -3.52 | Upgrade |
Gain (Loss) on Sale of Assets | -0.17 | -0.2 | -0.09 | -0.06 | -0.58 | 3.36 | Upgrade |
Asset Writedown | -6.09 | -2.13 | -4.52 | -16.96 | -16.7 | -148.15 | Upgrade |
Other Unusual Items | 12.21 | 9.75 | 4.71 | 12.34 | 7.03 | 8.04 | Upgrade |
Pretax Income | 311.16 | 293.32 | 329.7 | 250.21 | 178.89 | 63.74 | Upgrade |
Income Tax Expense | 44.65 | 45.85 | 53.23 | 37.92 | 38.93 | 35.82 | Upgrade |
Earnings From Continuing Operations | 266.51 | 247.47 | 276.47 | 212.29 | 139.96 | 27.93 | Upgrade |
Minority Interest in Earnings | -41.72 | -34.81 | -28.77 | -0.06 | 20.74 | 83.07 | Upgrade |
Net Income | 224.79 | 212.65 | 247.7 | 212.23 | 160.7 | 110.99 | Upgrade |
Net Income to Common | 224.79 | 212.65 | 247.7 | 212.23 | 160.7 | 110.99 | Upgrade |
Net Income Growth | 3.79% | -14.15% | 16.71% | 32.06% | 44.79% | - | Upgrade |
Shares Outstanding (Basic) | 819 | 814 | 814 | 814 | 814 | 814 | Upgrade |
Shares Outstanding (Diluted) | 819 | 814 | 814 | 814 | 814 | 814 | Upgrade |
Shares Change (YoY) | 0.62% | -0.01% | 0.02% | -0.00% | -0.03% | 0.03% | Upgrade |
EPS (Basic) | 0.27 | 0.26 | 0.30 | 0.26 | 0.20 | 0.14 | Upgrade |
EPS (Diluted) | 0.27 | 0.26 | 0.30 | 0.26 | 0.20 | 0.14 | Upgrade |
EPS Growth | 3.15% | -14.13% | 16.69% | 32.07% | 44.83% | - | Upgrade |
Free Cash Flow | 334.83 | 280.1 | 262.93 | 296.8 | 225.02 | 209.75 | Upgrade |
Free Cash Flow Per Share | 0.41 | 0.34 | 0.32 | 0.36 | 0.28 | 0.26 | Upgrade |
Dividend Per Share | 0.079 | 0.079 | 0.092 | 0.080 | 0.060 | 0.041 | Upgrade |
Dividend Growth | -14.67% | -14.67% | 15.00% | 33.33% | 46.34% | - | Upgrade |
Gross Margin | 50.81% | 48.67% | 48.33% | 46.15% | 45.56% | 45.75% | Upgrade |
Operating Margin | 17.95% | 16.62% | 19.76% | 13.44% | 11.53% | 16.68% | Upgrade |
Profit Margin | 15.51% | 15.17% | 16.38% | 13.49% | 11.83% | 8.66% | Upgrade |
Free Cash Flow Margin | 23.11% | 19.98% | 17.39% | 18.87% | 16.57% | 16.37% | Upgrade |
EBITDA | 328.2 | 307.95 | 382.89 | 319.43 | 257.8 | 297.72 | Upgrade |
EBITDA Margin | 22.65% | 21.96% | 25.33% | 20.31% | 18.99% | 23.23% | Upgrade |
D&A For EBITDA | 67.99 | 74.94 | 84.21 | 108.07 | 101.29 | 83.99 | Upgrade |
EBIT | 260.2 | 233 | 298.69 | 211.36 | 156.51 | 213.73 | Upgrade |
EBIT Margin | 17.95% | 16.62% | 19.76% | 13.44% | 11.53% | 16.68% | Upgrade |
Effective Tax Rate | 14.35% | 15.63% | 16.14% | 15.16% | 21.76% | 56.19% | Upgrade |
Revenue as Reported | 1,449 | 1,402 | 1,512 | 1,573 | 1,358 | 1,281 | Upgrade |
Advertising Expenses | - | 13.69 | 13.65 | 7.27 | 11.6 | 17.18 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.